massive pulmonary embolism - Nursing Case Study

Pathophysiology

• Primary mechanism: Acute obstruction of the pulmonary artery by a thrombus leads to a sudden increase in pulmonary vascular resistance, causing acute right ventricular (RV) overload and potential RV failure as the RV struggles to maintain cardiac output against increased afterload.

• Secondary mechanism: Impaired gas exchange due to ventilation-perfusion mismatch results from reduced perfusion to ventilated areas, leading to hypoxemia and further strain on the cardiovascular system.

• Key complication: Reduced cardiac output and systemic hypotension may occur due to compromised RV function, risking cardiogenic shock and multi-organ failure if not rapidly addressed.

Patient Profile

Demographics:

65-year-old male, retired construction worker

History:

• Key past medical history: History of deep vein thrombosis, hypertension, chronic obstructive pulmonary disease (COPD), and a recent hip replacement surgery

• Current medications: Warfarin, Lisinopril, Albuterol inhaler, Ibuprofen as needed

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Sudden onset of severe shortness of breath and chest pain

• Key symptoms: Acute dyspnea, pleuritic chest pain, hemoptysis, lightheadedness, and diaphoresis

• Vital signs: Blood pressure 85/60 mmHg, heart rate 135 bpm, respiratory rate 30 breaths per minute, oxygen saturation 78% on room air, temperature 37.2°C (99°F)

Section 1

New Diagnostic Results:

Following the initial assessment, the clinical team prioritizes obtaining diagnostic imaging and laboratory tests to confirm the suspected massive pulmonary embolism and assess the extent of cardiopulmonary compromise. A CT pulmonary angiogram is urgently performed, revealing a large saddle embolus straddling the bifurcation of the main pulmonary artery and extending into both the right and left pulmonary arteries. This finding confirms a significant obstruction to pulmonary blood flow, correlating with the patient's severe hypoxemia and hemodynamic instability. Additionally, a bedside echocardiogram shows evidence of right ventricular dilation and hypokinesis, indicating acute right heart strain and impending failure.

Laboratory results further elucidate the patient's critical condition. Arterial blood gases reveal severe hypoxemia with a partial pressure of oxygen (PaO2) of 48 mmHg, and a respiratory alkalosis with a pH of 7.48 and a partial pressure of carbon dioxide (PaCO2) of 30 mmHg, reflecting the patient's compensatory hyperventilation. Elevated D-dimer levels support the presence of a thrombotic event, while troponin levels are slightly elevated, suggesting myocardial strain due to the increased workload on the right heart. The patient's INR is subtherapeutic at 1.5, raising concerns about inadequate anticoagulation despite being on warfarin, possibly due to dietary factors or recent medication changes.

These findings necessitate immediate and aggressive intervention to prevent further deterioration. The healthcare team considers thrombolytic therapy given the high risk of hemodynamic collapse, while simultaneously preparing for potential surgical embolectomy should the patient not stabilize. Close monitoring of hemodynamic parameters and oxygenation, as well as rapid decision-making, are critical as the team navigates this complex and life-threatening scenario.

Section 2

Change in Patient Status:

Despite the initiation of thrombolytic therapy, the patient's condition rapidly deteriorates. Approximately 30 minutes post-intervention, the patient exhibits signs of increased respiratory distress, with respiratory rate escalating to 38 breaths per minute and oxygen saturation plummeting to 82% on a non-rebreather mask. The patient becomes increasingly tachycardic with a heart rate of 138 beats per minute and demonstrates significant hypotension, with blood pressure dropping to 78/50 mmHg. Auscultation reveals diminished breath sounds bilaterally, and the patient is diaphoretic with cool, clammy skin, indicating worsening shock. Jugular venous distention is more prominent, suggesting further right heart failure.

Concurrent with these clinical signs, repeat arterial blood gases show a worsening hypoxemia with a PaO2 of 42 mmHg and a further drop in PaCO2 to 28 mmHg, highlighting the patient's ongoing hyperventilation and respiratory compromise. The clinical team quickly reevaluates the patient's status, considering the possibility of complications such as recurrent embolism or bleeding due to thrombolytic therapy. Given the profound hemodynamic instability, preparations for intubation and mechanical ventilation are made to secure the airway and optimize oxygenation. Additionally, the team contemplates transitioning to extracorporeal membrane oxygenation (ECMO) as a salvage therapy should conventional measures fail, while also urgently coordinating with cardiovascular surgery to assess the feasibility of surgical embolectomy. This critical juncture necessitates precise clinical judgment and swift action to mitigate the life-threatening implications of the patient's deteriorating condition.

Section 3

New Diagnostic Results:

As the clinical team works rapidly to stabilize the patient, additional diagnostic testing is conducted to gain deeper insights into the underlying causes of the patient's worsening condition. A stat echocardiogram is performed, revealing severe right ventricular dilation and dysfunction. The interventricular septum is seen bowing into the left ventricle, confirming the increased pressure overload on the right side of the heart. These findings are consistent with acute cor pulmonale secondary to massive pulmonary embolism. The echocardiogram also uncovers a patent foramen ovale, which poses a risk for paradoxical embolism, potentially complicating the clinical picture further.

Concurrently, laboratory results return, showing a marked elevation in D-dimer levels, which supports the initial diagnosis of thromboembolism. However, the patient's coagulation profile indicates a concerning trend: the international normalized ratio (INR) has increased to 3.8, and the activated partial thromboplastin time (aPTT) is significantly prolonged at 98 seconds, raising the suspicion of a coagulopathy potentially exacerbated by thrombolytic therapy. This hypercoagulable state, juxtaposed with the bleeding risk, presents a complex therapeutic conundrum, necessitating a reevaluation of anticoagulation strategies.

These diagnostic findings deepen the complexity of the case, demanding advanced clinical reasoning to balance the risks of further anticoagulation with the potential for bleeding. As the team deliberates on the next steps, including the possibility of initiating ECMO and the timing of surgical interventions, they must also consider the implications of the patent foramen ovale on the patient's management. The need for a multidisciplinary approach becomes evident, as cardiothoracic surgeons, hematologists, and intensivists are consulted to collaboratively devise a comprehensive care plan tailored to the patient's rapidly evolving clinical status.

Section 4

Change in Patient Status:

As the clinical team closely monitors the patient, a sudden change in status is observed. The patient becomes acutely hypotensive, with blood pressure dropping to 78/50 mmHg, and tachycardic with a heart rate now surging to 132 beats per minute. Oxygen saturation declines to 82% on a non-rebreather mask, despite maximal supplemental oxygen. The patient exhibits increased work of breathing and is visibly diaphoretic, indicating a significant deterioration in hemodynamic stability. Arterial blood gas analysis reveals profound respiratory acidosis with a pH of 7.21, PaCO2 of 58 mmHg, and PaO2 of 55 mmHg, reflective of severe ventilation-perfusion mismatch and impaired gas exchange.

In light of these developments, the decision is made to escalate respiratory support by initiating mechanical ventilation. However, the team faces the challenge of managing the patient's delicate hemodynamic balance while preventing further right ventricular strain. Continuous infusion of vasopressors, including norepinephrine, is started to maintain perfusion pressure, but there is a fine line between supporting cardiac output and exacerbating the right ventricular dysfunction. The intensivists consider the potential benefits and risks of ECMO support, weighing it against the patient's bleeding risk and the potential need for surgical intervention to address the patent foramen ovale.

This critical juncture demands robust interdisciplinary collaboration, as each intervention must be carefully timed and coordinated to optimize patient outcomes. The team must also be vigilant for signs of paradoxical embolism due to the patent foramen ovale, which could further complicate the clinical picture. As the patient's condition remains precarious, the focus shifts to maintaining stability while preparing for potential emergent interventions, highlighting the complexity of managing massive pulmonary embolism with concurrent cardiovascular compromise.

Section 5

As the clinical team initiates mechanical ventilation, they closely monitor the patient's hemodynamic response to the intervention. The initial ventilator settings are carefully selected to minimize intrathoracic pressure and reduce right ventricular afterload, with a focus on lung-protective strategies to mitigate barotrauma. However, despite these precautions, the patient's blood pressure remains critically low, with systolic readings struggling to stay above 80 mmHg despite escalating doses of norepinephrine. Lactate levels rise to 5.2 mmol/L, indicating worsening tissue perfusion and the potential onset of shock. The team reevaluates their approach, considering the addition of inotropic support with dobutamine to enhance cardiac contractility and improve systemic circulation.

Simultaneously, a repeat transthoracic echocardiogram is performed to assess right ventricular function and evaluate for any new findings. The echocardiogram reveals severe right ventricular dilation and systolic dysfunction, with evidence of septal bowing consistent with right ventricular pressure overload. Intriguingly, there is visible shunting across the patent foramen ovale, raising concerns about paradoxical embolism. In light of these findings, the team discusses the potential for a trial of inhaled nitric oxide to selectively reduce pulmonary vascular resistance and improve right ventricular function, recognizing the need for careful monitoring of systemic effects.

As the patient's condition remains tenuous, the intensivists contemplate the feasibility of advanced interventions such as ECMO to provide cardiopulmonary support while addressing the risk of intracardiac shunting and systemic embolization. The decision-making process is further complicated by the patient's coagulopathy, evidenced by a prolonged aPTT of 75 seconds and platelet count dropping to 85,000/mm^3, necessitating a delicate balance between anticoagulation for the pulmonary embolism and the risk of hemorrhagic complications. The multidisciplinary team, including cardiology, pulmonology, and hematology, convenes urgently to strategize management, underscoring the critical need for coordinated care in navigating the complexities of this life-threatening scenario.